This study aimed to investigate the effect of decontamination by rifaximin in severe alcoholic hepatitis patients. Patients who take corticosteroid or pentoxifylline will be randomly allocated to rifaximin group or control group.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
170
400mg three times per day for 28 days
Corticosteroid 40mg/day or pentoxifylline 400mg three times per day for 28 days
Mortality
Time frame: 6-month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.